No Data
IIF, Frontier I, and others.
＜260A＞A business partnership has been established between High Resolution, which is engaged in the Alte GPU business, and the next-generation Datacenter project "alt GPU Cloud". ＜278A＞Acquisition of shares in Terra DX Solutions, which operates disaster recovery services and construction management software, has been made by a subsidiary. ＜2997＞Acquisition of A-REIT ETF for sales-related properties (land in Nerima, Tokyo, and Kawasaki, Kanagawa). ＜3133＞Kaihatsu has initiated a new business. ＜3664＞Mobcast HD has its 35th stock option.
TMS Partners With Tokushima University for Joint Research
TIM has concluded a joint research agreement with Tokushima Universities.
TIM <4891.T> announced on the 26th that it has concluded a joint research agreement with Universities in Tokushima. This joint research will examine the pharmacological effects of a newly discovered soluble epoxy hydrolase (sEH) inhibitor identified in the company's internal program. On the 26th, the closing price was 209 yen, down 1 yen compared to the previous day. Provided by Wealth Advisor Inc.
Stable, possibly maintaining a solid base after the Sell has run its course.
[Emerging Markets Individual Stock Global Strategy] Today's Emerging Markets are expected to show a steady performance. In the US stock market on the 26th, the Dow Inc fell by 188.04 points (-0.43%) to 19,075.26 dollars, marking a pullback after three days. Buys supported by some retail companies' earnings reports and the decline in long-term interest rates bolstered stock prices. On the other hand, concerns about the economic and inflation impacts emerged after President Trump revealed plans for the announcement of tariffs against Europe, putting pressure on stock prices. Today
TMS' Stroke Treatment JX10 Secures China Nod for Clinical Study
Agile, FLN and others [Emerging Markets Press Release]
Large exercise of the 15th subscription rights (with price adjustment clause) for LAHD starting from the 20th, number of shares to be delivered, 0.01 million 1000 shares. Approval for clinical trial application of TIMS TMS-007 (JX10) in China. Genova Ltd. Share Buyback, with a maximum of 1 million stocks (7.21% of issued stocks), will be purchased on the 21st at ToSTNeT-3. Termination of the business partnership with Hitachi Industrial Equipment Systems, which is engaged in manufacturing. New shareholder benefit program for Agile.